Po-653-02 mortality related to antiarrhythmic choice among patients with atrial fibrillation and left ventricular hypertrophy
Heart Rhythm(2022)
Abstract
Current atrial fibrillation (AF) guidelines recommend only amiodarone or dronedarone as antiarrhythmic drugs (AAD) in patients with left ventricular hypertrophy (LVH), due to a postulated pro-arrhythmic risk. However, there are limited clinical data to support these recommendations.
MoreTranslated text
Key words
Atrial Fibrillation
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined